ArticleEClinicalMedicine2025

Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial.

Niels Rahe-Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.